Beyaz and Singulair drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Beyaz (drospirenone; ethinyl estradiol; levomefolate calcium) and Singulair (montelukast sodium). Common drug interactions include deep vein thrombosis among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Beyaz and Singulair. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.

What is Beyaz?

Beyaz has active ingredients of drospirenone; ethinyl estradiol; levomefolate calcium. It is often used in birth control. eHealthMe is studying from 2,012 Beyaz users. Check the latest studies of Beyaz.

What is Singulair?

Singulair has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 129,752 Singulair users. Check the latest studies of Singulair.



On Jul, 12, 2026

46 people who take Beyaz and Singulair together, and have interactions are studied.

Beyaz and Singulair drug interactions.

What are the common drug interactions of Beyaz and Singulair, by gender? *:

female:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Injury
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Pain
  5. Emotional distress
  6. Sinusitis (inflammation of sinus)
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Pulmonary congestion (congestion in the lungs)
  9. Scar
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Emotional distress
  3. Acute hepatic failure
  4. Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
  5. Cardiogenic shock (inadequate circulation of blood)
  6. Chest pain
  7. Cold sweat
  8. Haemodynamic instability (disturbances in the blood movement in our body)
  9. Hypoperfusion (decreased blood flow through an organ)
  10. Hypotension (abnormally low blood pressure)

What are the common drug interactions of Beyaz and Singulair, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Anxiety
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Nightmare (unpleasant dream)
  4. Vena cava thrombosis (clotting of the blood in large vein carrying deoxygenated blood into the heart)

20-29:

  1. Hysterectomy
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Syncope (loss of consciousness with an inability to maintain postural tone)
  4. Drug hypersensitivity
  5. Methaemoglobinaemia (a disorder characterized by the presence of a higher than normal level of methemoglobin in blood)
  6. Pulmonary embolism (blockage of the main artery of the lung)
  7. Pulmonary sarcoidosis (growth of tiny collections of inflammatory cells in lungs)
  8. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands)
  9. Alopecia (absence of hair from areas of the body)
  10. Blood cholesterol increased

30-39:

  1. Dyspnoea (difficult or laboured respiration)
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Aphasia (damage to the parts of the brain that control language)
  4. Insomnia (sleeplessness)
  5. Oropharyngeal pain
  6. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Joint injury
  10. Limb injury

40-49:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Emotional distress
  5. General physical health deterioration (weak health status)
  6. Injury
  7. Pain
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Embolism venous (embolus may pass into the arterial system)
  10. Headache (pain in head)

50-59:

  1. Acute hepatic failure
  2. Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
  3. Cardiogenic shock (inadequate circulation of blood)
  4. Chest pain
  5. Cold sweat
  6. Dyspnoea (difficult or laboured respiration)
  7. Emotional distress
  8. General physical health deterioration (weak health status)
  9. Haemodynamic instability (disturbances in the blood movement in our body)
  10. Hypoperfusion (decreased blood flow through an organ)

60+:

  1. Emotional distress
  2. Injury
  3. Asthenia (weakness)
  4. Dyspnoea (difficult or laboured respiration)
  5. Fatigue (feeling of tiredness)
  6. General physical health deterioration (weak health status)
  7. Insomnia (sleeplessness)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Ocular icterus (presence of jaundice seen in the sclera of the eye)
  10. Pain

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 18 people, 39.13%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 11 people, 23.91%
  3. Immunodeficiency Common Variable: 7 people, 15.22%
  4. Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 4 people, 8.70%
  5. Stress And Anxiety: 3 people, 6.52%
  6. Sinusitis (inflammation of sinus): 3 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Beyaz and Singulair?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Beyaz and Singulair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Beyaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Singulair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Beyaz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Singulair and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on drospirenone; ethinyl estradiol; levomefolate calcium and montelukast sodium (the active ingredients of Beyaz and Singulair, respectively), and Beyaz and Singulair (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: